Skip to content

The effects of memory extinction following methadone administration on heroin craving and relapse

A novel methadone-induced memory retrieval-extinction procedure to prevent heroin craving and relapse

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026460
Enrollment
Unknown
Registered
2019-10-11
Start date
2015-10-19
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heroin Addiction

Interventions

Methadone-10 Min-Extinction:Extinction sessions were administered 10 min after methadone intake 3 times per week for 4 weeks.
Methadone:Take methadone as usual
Methadone-6h-Extinction:Extinction sessions were administered 10 min after methadone intake 3 times per week for 4 weeks.

Sponsors

National Institute on Drug Dependence, Peking University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: The participants had to be men aged between 18 and 55 years old who met the diagnostic criteria of heroin dependence according to the criteria of Diagnostic and Statistical Manual of Mental Disorders, forth edition (DSM-IV) (meeting three or more of seven criteria listed in DSM-IV, including tolerance or withdrawal). They were prescribed methadone maintenance treatment (MMT) and took it regularly, had normal blood pressure and heart rate (systolic pressure 140 mmHg; diastolic pressure 90 mmHg; heart rate 100bpm, and provided signed consent forms.

Exclusion criteria

Exclusion criteria: Participants were excluded if they had used addictive drugs other than heroin based on self-reporting or had a positive urine test results during either the recruitment screening or testing, had a current or past history of DSM-IV Axis I disorders, were currently using antidepressants or had depression diagnosed, had clinically evident cognitive impairment, or had self-reported treatment with any prescription drugs during the study period.

Design outcomes

Primary

MeasureTime frame
Drug craving;Morphine urine test;

Countries

China

Contacts

Public ContactJie Shi

Pekin University

shijie@bjmu.edu.cn+86 01082801593

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026